News
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure. Chimeric antigen receptor (CAR) T cell therapy is one of the most promising cancer treatments.
Formée à Genève et aux Pays-Bas, Camille Nemitz-Piguet est psychiatre et psychothérapeute d'orientation systémique. Elle est ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback